Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?

MAE van de Sande, CL Creutzberg, Steven Water, Abdul Sharfo, Mischa Hoogeman

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)


In this dosimetric comparison study it was shown that IMPT with robust planning reduces dose to surrounding organs in cervical and endometrial cancer treatment compared with IMRT. Especially for the para-aortic region, clinically relevant dose reductions were obtained for kidneys, spinal cord and bowel, justifying the use of proton therapy for this indication. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)397-403
Number of pages7
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - 2016

Cite this